These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1136862)

  • 1. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester, in lymphoproliferative disorders. I. chronic lymphocytic leukaemia.
    Brandt L; Kónyves I; Móller TR
    Acta Med Scand; 1975 Apr; 197(4):317-22. PubMed ID: 1136862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.
    Móller TR; Brandt L; Kónyves I; Lindberg G
    Acta Med Scand; 1975 Apr; 197(4):323-7. PubMed ID: 1173538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
    Lutz D; Böhnel J
    Osterr Z Onkol; 1977; 3(5-6):155-9. PubMed ID: 323777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087).
    Aungst CW; Mittelman A; Murphy GP
    J Surg Oncol; 1975; 7(6):457-60. PubMed ID: 1102806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
    Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
    Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
    Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
    Biomedicine; 1977 Jun; 27(4):158-61. PubMed ID: 329910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia.
    Han T; Ezdinli EZ; Shimaoka K; Desai DV
    Cancer; 1973 Mar; 31(3):502-8. PubMed ID: 4693581
    [No Abstract]   [Full Text] [Related]  

  • 9. Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas.
    Mattsson W; von Eyben F; Turesson I; Wählby S
    Cancer; 1978 Jan; 41(1):112-6. PubMed ID: 342081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic granulocytic leukaemia and chronic lymphocytic leukaemia.
    Spiers AS
    Br Med J; 1974 Nov; 4(5942):460-2. PubMed ID: 4279128
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phase II study of chlorambucil in patients with hematological malignancies].
    Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2672-5. PubMed ID: 3307632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Principles of current chemotherapy of lymphocytic leukemia (review of the literature)].
    Ogonovskiĭ TM
    Vrach Delo; 1979 Jan; (1):36-41. PubMed ID: 106553
    [No Abstract]   [Full Text] [Related]  

  • 13. [KM 2210 therapy for chronic lymphocytic leukemia].
    Mori M; Murai Y; Miwa A; Fukayama M; Ikebuchi K; Nakamura N; Kaise M
    Gan No Rinsho; 1983 Dec; 29(15):1788-90. PubMed ID: 6689433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Busulphan toxicity syndrome caused by chlorambucil.
    Rose MS
    Br Med J; 1975 Apr; 2(5963):123. PubMed ID: 1125703
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisolone.
    Drake WM; Monson JP; Trainer PJ; Sharief M; Dick JP; Kelsey SM
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):564. PubMed ID: 9576561
    [No Abstract]   [Full Text] [Related]  

  • 16. Prednimustine in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hellbe L
    Acta Derm Venereol; 1979; 59(1):87-8. PubMed ID: 84481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal damage induced by chlorambucil in chronic lymphocytic leukaemia.
    Lawler SD; Lele KP
    Scand J Haematol; 1972; 9(6):603-12. PubMed ID: 4644424
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of chronic leukaemia.
    Israëls MC
    Practitioner; 1966 Jan; 196(171):91-5. PubMed ID: 5216342
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation.
    Shustik C; Mick R; Silver R; Sawitsky A; Rai K; Shapiro L
    Hematol Oncol; 1988; 6(1):7-12. PubMed ID: 3277904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal interstitial pneumonitis following high-dose intermittent chlorambucil therapy for chronic lymphocyte leukemia.
    Lane SD; Besa EC; Justh G; Joseph RR
    Cancer; 1981 Jan; 47(1):32-6. PubMed ID: 7459812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.